Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:43 pm | May 09, 2023
UnitedHealth Group's other core segment, UnitedHealthcare, saw revenues grow 13% to $70.5 billion.
By Jeff Lagasse | 01:02 pm | May 09, 2023
The requirements would result in federal savings, but would pass costs on to states and cause large coverage losses, data shows.
By Jeff Lagasse | 11:16 am | May 09, 2023
An Independent Special Committee will review options, ranging from potential sale to recapitalization or partnerships.
By Jeff Lagasse | 04:16 pm | May 08, 2023
The new Centers for Clinical Advancement are designed to bridge the gap between the classroom and bedside through practice-based instruction.
By Jeff Lagasse | 02:13 pm | May 08, 2023
The partnership will launch in South Carolina and Georgia this year and then expand to five more states in 2024.
By Jeff Lagasse | 11:10 am | May 08, 2023
Out of the improper payments, $348 million were for telehealth-based psychotherapy services.
By Jeff Lagasse | 03:57 pm | May 05, 2023
The company pledges more transparency around its PBM business, run through the Evernorth subsidiary.
By Jeff Lagasse | 12:15 pm | May 05, 2023
Lawmakers expressed concern that the DEA's plan to roll back flexibilities could make OUD medication more difficult to obtain.
By Jeff Lagasse | 03:30 pm | May 04, 2023
The growth in enrollment is due to a number of factors, said KFF, including the attraction of extra benefits offered by most plans.
By Jeff Lagasse | 10:25 am | May 04, 2023
Still, Eli Lilly is touting the results, which demonstrate effectiveness at slowing the progression of the disease.